1-20 of 66
Yue Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

DPP9 Stabilizes NRF2 to Suppress Ferroptosis and Induce Sorafenib Resistance in Clear Cell Renal Cell Carcinoma

Kun Chang, Yingji Chen, Xuanzhi Zhang, Wei Zhang, Ning Xu, Bohan Zeng, Yue Wang, Tao Feng, Bo Dai, Fujiang Xu, Dingwei Ye, Chenji Wang
Journal: Cancer Research
Cancer Res (2023) 83 (23): 3940–3955.
https://doi.org/10.1158/0008-5472.CAN-22-4001
Published: 01 December 2023
View article titled, DPP9 Stabilizes NRF2 to Suppress Ferroptosis and Induce Sorafenib Resistance in Clear Cell Renal Cell Carcinoma
Open the PDF for DPP9 Stabilizes NRF2 to Suppress Ferroptosis and Induce Sorafenib Resistance in Clear Cell Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer

Aditi S. Khatpe, Rebecca Dirks, Poornima Bhat-Nakshatri, Henry Mang, Katie Batic, Sarah Swiezy, Jacob Olson, Xi Rao, Yue Wang, Hiromi Tanaka, Sheng Liu, Jun Wan, Duojiao Chen, Yunlong Liu, Fang Fang, Sandra Althouse, Emily Hulsey, Maggie M. Granatir, Rebekah Addison, Constance J. Temm, George Sandusky, Audrey Lee-Gosselin, Kenneth Nephew, Kathy D. Miller, Harikrishna Nakshatri
Journal: Cancer Research
Cancer Res (2023) 83 (8): 1345–1360.
https://doi.org/10.1158/0008-5472.CAN-22-3667
Published: 14 April 2023
View article titled, TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer
Open the PDF for TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract 5458: TONSL is an immortalizing oncogene of the chromosome 8q24.3 amplicon and new therapeutic target in breast cancer

Aditi S. Khatpe, Rebecca Dirks, Poornima Bhat-Nakshatri, Henry Mang, Katie Batic, Sarah Swiezy, Jacob Olson, Xi Rao, Yue Wang, Hiromi Tanaka, Sheng Liu, Jun Wan, Duojiao Chen, Yunlong Liu, Fang Fang, Sandra Althouse, Emily Hilsey, Maggie M. Granatir, Rebekah Addison, Constance J. Temm, George Sandusky, Audrey Lee-Gosselin, Kenneth Nephew Nephew, Kathy D. Miller, Harikrishna Nakshatri
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 5458.
https://doi.org/10.1158/1538-7445.AM2023-5458
Published: 04 April 2023
View article titled, Abstract 5458: TONSL is an immortalizing oncogene of the chromosome 8q24.3 amplicon and new therapeutic target in breast cancer
Journal Articles

Abstract 296: Antigen-independent delivery of 4-1BB agonist to the tumor microenvironment improves immune response while reducing hepatotoxicity

Hyesun Hyun, Bo Sun, Stephanie A. Montgomery, Teresa Griffin, Juanzhu Yan, Albert Wielgus, Yue Wang, Tian Zhang, Jianjun Cheng, Andrew Z. Wang
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 296.
https://doi.org/10.1158/1538-7445.AM2022-296
Published: 15 June 2022
View article titled, Abstract 296: Antigen-independent delivery of 4-1BB agonist to the tumor microenvironment improves immune response while reducing hepatotoxicity
Journal Articles

Abstract 6199: Fusion genes: Novel therapeutic targets for gastric signet ring cell carcinoma

Yue Wang, Tao Shi, Xuan Wang, Jinwei Hu, Lixia Yu, Qin Liu, Nandie Wu, Baorui Liu, Jia Wei
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 6199.
https://doi.org/10.1158/1538-7445.AM2022-6199
Published: 15 June 2022
View article titled, Abstract 6199: Fusion genes: Novel therapeutic targets for gastric signet ring cell carcinoma
Journal Articles

Abstract 6176: CD56 dim+ immune infiltration and reprogrammed TMEs associated with response to neoadjuvant anti-PD-1 immunotherapy plus concurrent chemoradiotherapy in locally advanced gastric or gastroesophageal junction adenocarcinoma

Jia Wei, Qin Liu, Hui Chen, Xin Zhang, Feilong Zhao, Yao Fu, Ju Yang, Yue Wang, Shiqing Chen, Xiaochen Zhao, Yuezong Bai, Wenxian Guan, Baorui Liu
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 6176.
https://doi.org/10.1158/1538-7445.AM2022-6176
Published: 15 June 2022
View article titled, Abstract 6176: CD56 dim<sup>+</sup> immune infiltration and reprogrammed TMEs associated with response to neoadjuvant anti-PD-1 immunotherapy plus concurrent chemoradiotherapy in locally advanced gastric or gastroesophageal junction adenocarcinoma
Journal Articles

Abstract 5594: Systematic identification of the chemo-immunotherapy synergism to overcome immunotherapy resistance in cancer

Yue Wang, Yifei Wang, Xiaofei Wang, Zehua Wang, Min Zhang, Da Yang
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 5594.
https://doi.org/10.1158/1538-7445.AM2022-5594
Published: 15 June 2022
View article titled, Abstract 5594: Systematic identification of the chemo-immunotherapy synergism to overcome immunotherapy resistance in cancer
Journal Articles

Abstract OT1-17-02: A phase II study of pembrolizumab plus fulvestrant in hormone receptor positive, HER-2 negative advanced/metastatic breast cancer patients

Nancy Chan, Dirk Moore, Pavankumar Tandra, Jatin Rana, Coral Omene, Mridula George, Jairam Krishnamurthy, Shruti Desai, Nayana Patel, Yue Wang, Marc Bicomong, Xiao-wei Tan, Kim Hirshfield, Shridar Ganesan, Deborah Toppmeyer
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): OT1-17-02.
https://doi.org/10.1158/1538-7445.SABCS21-OT1-17-02
Published: 15 February 2022
View article titled, Abstract OT1-17-02: A phase II study of pembrolizumab plus fulvestrant in hormone receptor positive, HER-2 negative advanced/metastatic breast cancer patients
Journal Articles

Abstract P2-12-15: Neoadjuvant liposomal doxorubicin and carboplatin is effective and tolerable for the treatment of early stage triple negative breast cancer

Nancy Chan, Shou-en Lu, Yue Wang, Gregory M Riedlinger, Coral Omene, Mridula George, Jyoti Malhotra, Maria Kowzun, Firas G Eladoumikdachi, Lindsay B Potdevin, Shicha Kumar, Kant Matsuda, Shruti Desai, Nayana Patel, Deborah L Toppmeyer, Shridar Ganesan, Kim Hirshfield
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P2-12-15.
https://doi.org/10.1158/1538-7445.SABCS21-P2-12-15
Published: 15 February 2022
View article titled, Abstract P2-12-15: Neoadjuvant liposomal doxorubicin and carboplatin is effective and tolerable for the treatment of early stage triple negative breast cancer
Journal Articles

Abstract 2249: Molecular landscape and actionable alterations in Chinese soft-tissue sarcoma patients

Hua Bao, Yue Wang, Rui Liu, Xue Wu, Yang Shao
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 2249.
https://doi.org/10.1158/1538-7445.AM2021-2249
Published: 01 July 2021
View article titled, Abstract 2249: Molecular landscape and actionable alterations in Chinese soft-tissue sarcoma patients
Journal Articles

Tumor Fibroblast–Derived FGF2 Regulates Expression of SPRY1 in Esophageal Tumor–Infiltrating T Cells and Plays a Role in T-cell Exhaustion

Qing-yun Chen, Yi-ni Li, Xin-yue Wang, Xu Zhang, Yi Hu, Lei Li, Da-qin Suo, Ke Ni, Zhuo Li, Jia-rong Zhan, Ting-ting Zeng, Ying-hui Zhu, Yan Li, Li-jia Ma, Xin-Yuan Guan
Journal: Cancer Research
Cancer Res (2020) 80 (24): 5583–5596.
https://doi.org/10.1158/0008-5472.CAN-20-1542
Published: 15 December 2020
View article titled, Tumor Fibroblast–Derived FGF2 Regulates Expression of SPRY1 in Esophageal Tumor–Infiltrating T Cells and Plays a Role in T-cell Exhaustion
Open the PDF for Tumor Fibroblast–Derived FGF2 Regulates Expression of SPRY1 in Esophageal Tumor–Infiltrating T Cells and Plays a Role in T-cell Exhaustion in another window
Includes: Supplementary data
Journal Articles

ERINA Is an Estrogen-Responsive LncRNA That Drives Breast Cancer through the E2F1/RB1 Pathway

Zihui Fang, Yue Wang, Zehua Wang, Meishu Xu, Songrong Ren, Da Yang, Mei Hong, Wen Xie
Journal: Cancer Research
Cancer Res (2020) 80 (20): 4399–4413.
https://doi.org/10.1158/0008-5472.CAN-20-1031
Published: 15 October 2020
View article titled, <em>ERINA</em> Is an Estrogen-Responsive LncRNA That Drives Breast Cancer through the E2F1/RB1 Pathway
Open the PDF for <em>ERINA</em> Is an Estrogen-Responsive LncRNA That Drives Breast Cancer through the E2F1/RB1 Pathway in another window
Includes: Supplementary data
Journal Articles

Circadian Rhythm Is Disrupted by ZNF704 in Breast Carcinogenesis

Chao Yang, Jiajing Wu, Xinhua Liu, Yue Wang, Beibei Liu, Xing Chen, Xiaodi Wu, Dong Yan, Lulu Han, Shumeng Liu, Lin Shan, Yongfeng Shang
Journal: Cancer Research
Series: Author Choice
Cancer Res (2020) 80 (19): 4114–4128.
https://doi.org/10.1158/0008-5472.CAN-20-0493
Published: 02 October 2020
View article titled, Circadian Rhythm Is Disrupted by ZNF704 in Breast Carcinogenesis
Open the PDF for Circadian Rhythm Is Disrupted by ZNF704 in Breast Carcinogenesis in another window
Includes: Supplementary data
Journal Articles

Abstract 1072: Lymphangiogenesis-inducing vaccines for melanoma treatment elicit potent tumor-specific T cell immunity and long-term tumor control

Maria Stella Sasso, Nikolaos Mitrousis, Sylvie Hauert, Priscilla S. Briquez, Yue Wang, Jun Ishihara, Jeffrey A. Hubbell, Melody A. Swartz
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 1072.
https://doi.org/10.1158/1538-7445.AM2020-1072
Published: 15 August 2020
View article titled, Abstract 1072: Lymphangiogenesis-inducing vaccines for melanoma treatment elicit potent tumor-specific T cell immunity and long-term tumor control
Journal Articles

Abstract 5178: MEDI7526: a novel bispecific antibody that activates the CD40 pathway and down-regulates cell surface PD-L1 expression

Yaya Wang, Sean Turman, Deepali Malhotra, Ryan Gilbreth, Yue Wang
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 5178.
https://doi.org/10.1158/1538-7445.AM2020-5178
Published: 15 August 2020
View article titled, Abstract 5178: MEDI7526: a novel bispecific antibody that activates the CD40 pathway and down-regulates cell surface PD-L1 expression
Journal Articles

Abstract 2267: MEDI5083, a novel CD40L-Fc fusion protein, activates the CD40 pathway on antigen-presenting cells and promotes robust anti-tumor immune responses in both hot and cold murine tumor models

Deepali Malhotra, Sean Turman, Kelly McGlinchey, Yaya Wang, Yue Wang
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 2267.
https://doi.org/10.1158/1538-7445.AM2020-2267
Published: 15 August 2020
View article titled, Abstract 2267: MEDI5083, a novel CD40L-Fc fusion protein, activates the CD40 pathway on antigen-presenting cells and promotes robust anti-tumor immune responses in both hot and cold murine tumor models
Journal Articles

Clonal Mutations Activate the NF-κB Pathway to Promote Recurrence of Nasopharyngeal Carcinoma

Rui You, You-Ping Liu, De-Chen Lin, Qing Li, Tao Yu, Xiong Zou, Mei Lin, Xiao-Long Zhang, Gui-Ping He, Qi Yang, Yi-Nuan Zhang, Yu-Long Xie, Rou Jiang, Chen-Yan Wu, Chao Zhang, Cheng Cui, Jing-Qi Wang, Yue Wang, Ai-Hua Zhuang, Gui-Fang Guo, Yi-Jun Hua, Rui Sun, Jing-Ping Yun, Zhi-Xiang Zuo, Ze-Xian Liu, Xiao-Feng Zhu, Tie-Bang Kang, Chao-Nan Qian, Hai-Qiang Mai, Ying Sun, Mu-Sheng Zeng, Lin Feng, Yi-Xin Zeng, Ming-Yuan Chen
Journal: Cancer Research
Cancer Res (2019) 79 (23): 5930–5943.
https://doi.org/10.1158/0008-5472.CAN-18-3845
Published: 02 December 2019
View article titled, Clonal Mutations Activate the NF-κB Pathway to Promote Recurrence of Nasopharyngeal Carcinoma
Open the PDF for Clonal Mutations Activate the NF-κB Pathway to Promote Recurrence of Nasopharyngeal Carcinoma in another window
Includes: Supplementary data
Journal Articles

Abstract 3963: Deep serial analysis of the TCR/BCR CDR3 adaptome repertoire in peripheral blood of pancreatic cancer patients in a randomized study of neoadjuvant chemotherapy with or without autophagy inhibition

Yue Wang, Michael T. Lotze
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 3963.
https://doi.org/10.1158/1538-7445.AM2019-3963
Published: 01 July 2019
View article titled, Abstract 3963: Deep serial analysis of the TCR/BCR CDR3 adaptome repertoire in peripheral blood of pancreatic cancer patients in a randomized study of neoadjuvant chemotherapy with or without autophagy inhibition
Journal Articles

Abstract 5232: PES1 is highly expressed and its biological function in gastrointestinal tumor

Qin Feng, Shenyi Lian, Ping Wang, Yue Wang, Zhongwu Li, Chengchao Shou, Tingting Ren, Dongmei Lin
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 5232.
https://doi.org/10.1158/1538-7445.AM2019-5232
Published: 01 July 2019
View article titled, Abstract 5232: PES1 is highly expressed and its biological function in gastrointestinal tumor
Journal Articles

Abstract 1534: MEDI5083, a novel CD40L-Fc fusion protein, activates the CD40 pathway on antigen presenting cells and promotes a robust anti-tumor immune response in a B16F10 murine tumor model

Sean Turman, Kelly McGlinchey, YaYa Wang, Deepali Malhotra, Ronald Herbst, Yue Wang
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 1534.
https://doi.org/10.1158/1538-7445.AM2019-1534
Published: 01 July 2019
View article titled, Abstract 1534: MEDI5083, a novel CD40L-Fc fusion protein, activates the CD40 pathway on antigen presenting cells and promotes a robust anti-tumor immune response in a B16F10 murine tumor model